AdaptHealth (AHCO) Income from Continuing Operations (2018 - 2026)
AdaptHealth's (AHCO) quarterly Income from Continuing Operations came in at 14873000.0 in Q1 2026, down 144.66% year-on-year from 33301276.98 in Q1 2025, and up 85.36% quarter-over-quarter from 101594000.0 in Q4 2025.
AdaptHealth (AHCO) Income from Continuing Operations (2018 - 2026) Analysis & Trends
AdaptHealth's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 14873000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 144.66% year-over-year to 14873000.0 in Q1 2026; TTM through Mar 2026 was 74889000.0, a 183.33% decrease from a year earlier, with the FY2025 full-year figure at 66054000.0, down 169.66% from the prior year.
- Income from Continuing Operations advanced to 14873000.0 in Q1 2026 per AHCO's latest filing, from 101594000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 51411000.0 in Q4 2024 and bottomed at 452899000.0 in Q3 2023.
- The 5-year median for Income from Continuing Operations is 15247000.0 (2022), against an average of 34579529.41.
- Across the five-year window, Income from Continuing Operations soared 1261.12% in 2022 and slumped 15381.01% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 1638000.0 in 2022, then slumped by 15381.01% to 253579000.0 in 2023, then soared by 120.27% to 51411000.0 in 2024, then sank by 297.61% to 101594000.0 in 2025, then soared by 85.36% to 14873000.0 in 2026.
- Per Business Quant, the three latest AHCO Income from Continuing Operations figures stand at 14873000.0 (Q1 2026), 101594000.0 (Q4 2025), and 25750000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AdaptHealth | 1.42 Bn | 1.38 Bn | 111.50 Mn | -14.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.87 Mn |
| Dec 31, 2025 | -101.59 Mn |
| Sep 30, 2025 | 25.75 Mn |
| Jun 30, 2025 | 15.83 Mn |
| Mar 31, 2025 | -6.08 Mn |
| Dec 31, 2024 | 51.41 Mn |
| Sep 30, 2024 | 23.96 Mn |
| Jun 30, 2024 | 20.58 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -253.58 Mn |
| Sep 30, 2023 | -452.90 Mn |
| Jun 30, 2023 | 15.04 Mn |
| Mar 31, 2023 | 16.66 Mn |
| Dec 31, 2022 | -1.64 Mn |
| Sep 30, 2022 | 17.21 Mn |
| Jun 30, 2022 | 15.25 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 23.48 Mn |
| Sep 30, 2021 | 58.27 Mn |
| Jun 30, 2021 | 80.06 Mn |